Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-11-03 12:17Core Viewpoint - The stock of Steady Medical (300888) has shown a decline in price and a mixed flow of funds, indicating potential volatility in investor sentiment and market performance [1][2]. Financial Performance - For the first three quarters of 2025, Steady Medical reported a main business revenue of 7.897 billion yuan, a year-on-year increase of 30.1% [3] - The net profit attributable to shareholders was 732 million yuan, up 32.36% year-on-year, while the net profit after deducting non-recurring gains and losses reached 679 million yuan, reflecting a 43.93% increase [3] - In Q3 2025, the company achieved a single-quarter main business revenue of 2.601 billion yuan, a 27.71% increase year-on-year, and a net profit of 240 million yuan, up 42.11% year-on-year [3] Market Position - Steady Medical's total market capitalization is 23.823 billion yuan, ranking 4th in the beauty and personal care industry [3] - The company has a net asset value of 12.263 billion yuan, leading the industry with a ranking of 1st [3] - The price-to-earnings ratio (P/E) stands at 24.41, significantly lower than the industry average of 39.95, ranking 2nd [3] Fund Flow Analysis - On November 3, 2025, the stock closed at 40.91 yuan, down 0.94%, with a turnover rate of 1.08% and a trading volume of 62,900 hands, amounting to a transaction value of 258 million yuan [1] - The net outflow of main funds was 9.6097 million yuan, accounting for 3.73% of the total transaction value, while retail investors saw a net inflow of 17.9136 million yuan, representing 6.95% of the total [1][2] Institutional Ratings - Over the past 90 days, 20 institutions have rated the stock, with 16 buy ratings and 4 hold ratings, indicating a generally positive outlook [4] - The average target price set by institutions in the last 90 days is 5.409 billion yuan [4]